OmniAb, Inc. (OABIW) stock
OABIWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as OABI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/309% above fair value
$0.41−0.01 (-2.38%)
Close on Oct 30, 2026Market cap $742.95MP/E –Yield –
OmniAb operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
OmniAb's operating cash flow for the twelve months ending Sep 30, 2026 was $2.67M. For fiscal 2025 it was -$36.46M. The highest annual figure on record is $2.35M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$36.46M | – |
| FY2024 | Dec 31, 2024 | -$39.66M | -1790.0% |
| FY2023 | Dec 31, 2023 | $2.35M | – |
| FY2022 | Dec 31, 2022 | -$3.59M | – |
| FY2021 | Dec 31, 2021 | -$5.67M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $10.58M | – |
| Q2 FY2026 | Jun 30, 2026 | $2.68M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.91M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.67M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.76M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.15M | – |
| Q1 FY2025 | Mar 31, 2025 | -$15.87M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.87M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.58M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.18M | – |
| Q1 FY2024 | Mar 31, 2024 | -$17.03M | -161.5% |
| Q4 FY2023 | Dec 31, 2023 | -$9.12M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.20M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.02M | – |
| Q1 FY2023 | Mar 31, 2023 | $27.69M | +137.9% |
| Q4 FY2022 | Dec 31, 2022 | -$7.14M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.23M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.85M | – |
| Q1 FY2022 | Mar 31, 2022 | $11.64M | – |